- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Distribution of top public funders for R&D on neglected diseases 2017
Distribution of top public funders for R&D on neglected diseases 2017
Percentage of top countries in public funding for research and development on neglected diseases in 2017*
This statistic shows the percentage of the top public funders for research and development on neglected diseases worldwide in 2017. In that year, the United States was responsible for some 69 percent of the total global funding for R&D on neglected diseases.
Percentage of top countries in public funding for research and development on neglected diseases in 2017*
Loading statistic...
Expand statistic
| Percentage of total funding | |
|---|---|
| United States | 69% |
| United Kingdom | 8% |
| European Union | 5.2% |
| India | 3.3% |
| Germany | 2.8% |
| France | 2% |
| Netherlands | 1% |
| Australia | 1% |
| Switzerland | 0.8% |
| Japan | 0.8% |
| South Africa | 0.6% |
| Canada | 0.6% |
| Percentage of total funding | |
|---|---|
| United States | 69% |
| United Kingdom | 8% |
| European Union | 5.2% |
| India | 3.3% |
| Germany | 2.8% |
| France | 2% |
| Netherlands | 1% |
| Australia | 1% |
| Switzerland | 0.8% |
| Japan | 0.8% |
| South Africa | 0.6% |
| Canada | 0.6% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic shows the percentage of the top public funders for research and development on neglected diseases worldwide in 2017. In that year, the United States was responsible for some 69 percent of the total global funding for R&D on neglected diseases.
Show more- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * Neglected Diseases are mostly tropical infectious diseases that receive less attention behind the big diseases (usually: HIV, malaria, tuberculosis) and are therefore labeled 'neglected'.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- 2017
- Supplementary notes
- * Neglected Diseases are mostly tropical infectious diseases that receive less attention behind the big diseases (usually: HIV, malaria, tuberculosis) and are therefore labeled 'neglected'.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Diseases
- 88 page/s
- English
- pptx
- Detailed references
Everything On "Diseases" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Diseases"
- Diseases as death causes - global
The most important statistics
- Leading causes of death worldwide in 2016 (in millions)Global death rate - leading causes 2016
- Leading 10 causes of death in low-income countries worldwide in 2016 (in deaths per 100,000 population)Top ten causes of deaths in low-income countries 2016
- Leading 10 causes of death in upper income countries in 2016 (in deaths per 100,000 population)Top ten causes of deaths in upper income countries 2016
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)Deaths caused by chronic diseases 2016
- Number of deaths caused by selected communicable diseases annually worldwide as of 2016 (in 1,000)Annual deaths number from communicable diseases 2016
- Leading 20 countries based on probability of mortality due to non-communicable diseases between ages 30 to 70 in 2016Countries with highest probable mortality due to non-communicable diseases 2016
- Diseases as death causes - U.S.
The most important statistics
- Distribution of most urgent health problems facing the U.S. perceived by Americans in 2016Most urgent health problems as perceived by Americans 2016
- Distribution of the 10 leading causes of death in the United States in 2017Leading causes of death in the United States 2017
- Rates of the 10 leading causes of death in the United States in 2017 (per 100,000 population)*Rates of the leading causes of death in the U.S. 2017
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by diseasePercentage changes in selected causes of death in the U.S. 2000-2017
- Cancer
The most important statistics
- Number of cancer deaths worldwide in 2016, by major type of cancerCancer deaths worldwide by major type 2016
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*Deaths by cancer in the U.S. 1950-2016
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)U.S. Americans with a history of cancer living 2004-2016
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017Availability of new cancer drugs by country as of 2017
- Heart diseases
The most important statistics
- Deaths from ischemic heart disease in OECD countries in 2015 (per 100,000 population)Ischemic heart disease - deaths in selected countries 2015
- Heart disease risk in the U.S. between 2000 and 2016, by age*Heart disease risk by age in the U.S. 2000-2016
- Deaths by heart diseases in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by heart diseases in the U.S. 1950-2016
- Diabetes
The most important statistics
- Estimated number of diabetics worldwide in 2017 and 2045 (in millions)Diabetics worldwide 2017 and 2045
- Number of U.S. Americans with diagnosed diabetes from 1980 to 2015 (in millions)*Number of U.S. Americans with diabetes 1980-2015
- Deaths by diabetes mellitus in the U.S. from 1950 to 2016 (per 100,000 population)Deaths by diabetes mellitus in the U.S. 1950-2016
- Leading U.S. states based on percentage of adults who ever had diabetes as of 2017*Percentage of U.S. adults with diabetes, by top U.S. states 2017
- Alzheimer/dementia
The most important statistics
- Cost of dementia healthcare pathways in select countries for 2015 (in million U.S. dollars)Dementia healthcare pathway costs in select countries 2015
- Projected numbers of older people with Alzheimer’s in the U.S. from 2010 to 2050 (in millions)*Projected numbers of older people with Alzheimer's in the U.S. 2010-2050
- Projected number of people aged 65 and over with Alzheimer's disease in the U.S. in 2019 and 2025, by state (in thousands)Total number of Alzheimer's disease elderly patients U.S. by state 2019 and 2025
- Distribution of Alzheimer's disease patients in the United States as of 2019, by age groupShare of patients with Alzheimer's disease in the U.S. by age group 2019
- Selected notifiable diseases - U.S.
The most important statistics
- Number of new cases of hepatitis A and B in the U.S. from 1970 to 2016New cases of hepatitis in the U.S. 1970-2016
- Number of new cases of Lyme disease in the U.S. from 1991 to 2016*New cases of Lyme disease in the U.S. 1991-2016
- Number of new cases of meningococcal disease in the U.S. from 1970 to 2016New cases of meningococcal disease in the U.S. 1970-2016
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019New cases of measles in the U.S. 1950-2019
- Number of new cases of syphilis in the U.S. from 1950 to 2016*New cases of syphilis in the U.S. 1950-2016
- Number of new cases of tuberculosis in the U.S. from 1960 to 2016*Number of new cases of tuberculosis in the U.S. 1960-2016
- Number of malaria cases in the U.S. from 2001 to 2015Malaria cases in the U.S. 2001-2015
- Research and development
The most important statistics
- Donated funds for research and development by disease in 2017 (in million U.S. dollars)*Research and development funding for diseases worldwide 2017
- Distribution of total global funding on research and development for selected diseases from 2013 to 2017Distribution of total funding on R&D for selected diseases 2013-2017
- Top countries in public funding for research and development on neglected diseases in 2017 (in million U.S. dollars)Top public funders for R&D on neglected diseases by country 2017
- Percentage of top countries in public funding for research and development on neglected diseases in 2017*Distribution of top public funders for R&D on neglected diseases 2017
- Top philanthropic funders for research and development on neglected diseases worldwide in 2017 (in million U.S. dollars)Leading philanthropic funders for research and development on neglected diseases 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Diseases: Top R & D funds among philanthropic foundations 2017
- U.S. government support for late-stage neglected disease pipeline candidates 2015
- Share of global at-risk population for malaria protected by IRS as of 2017, by region
- Immunization coverage for children at 24 months in Canada 2013 and 2015, by antigen
- Total U.S. disease investment 2008-2017 by disease
- Worldwide therapeutic licensing and acquisition deals 2008-2017 by disease type
- U.S. venture funding of therapeutic companies by disease type 2017
- Research and Development: charity donations for diseases 2007
- Chronic diseases: patients' responsibility
- U.S. disease investment by share of disease and investment type 2008-2017
- Ireland: Sport Ireland high performance sport investment in Canoeing Ireland 2013-19
- Deaths due to botulism in Europe 2017, by country
- England and Wales: number of people with diabetes 2013, by smoking status
- Sport Ireland high performance investments in the Irish Sailing Association 2013-2018
- Italy: share of funding allocated to performing arts 2018
- Ireland: Sport Ireland LSP funding 2014-2019
- Chile: distribution of funding to international organizations 2014-2016
- Ireland: Sport Ireland Dormant Account projects funding 2018
- Uruguay: distribution of funding to international organizations 2014-2016
- Chile: annual funding to international organizations 2014-2016, by type
Topics
Studies
- Pharmaceutical research and development
- G-Finder - Neglected Disease Research and Development 2018
- Clinical trials
- Biotechnology Industry in Europe
- G-Finder - Neglected Disease Research and Development 2017
- Doing our part: Innovating to fight Neglected Tropical Diseases (2017)
- Orphan drugs
- Drug use in the Nordic countries
- G-Finder - Neglected Disease Research and Development 2013
- G-Finder - Neglected Disease Research and Development 2015
- G-Finder - Neglected Disease Research and Development 2014
- G-Finder - Neglected Disease Research and Development 2012
- G-Finder - Neglected Disease Research and Development 2016
- Pharma R&D Annual Review 2019
- Measuring the return of pharmaceutical innovation 2018
Statistics on "Diseases"
- Leading causes of death worldwide in 2016 (in millions)
- Leading 10 causes of death in low-income countries worldwide in 2016 (in deaths per 100,000 population)
- Leading 10 causes of death in upper income countries in 2016 (in deaths per 100,000 population)
- Number of deaths caused by selected chronic diseases worldwide as of 2016 (in 1,000)
- Number of deaths caused by selected communicable diseases annually worldwide as of 2016 (in 1,000)
- Leading 20 countries based on probability of mortality due to non-communicable diseases between ages 30 to 70 in 2016
- Distribution of most urgent health problems facing the U.S. perceived by Americans in 2016
- Distribution of the 10 leading causes of death in the United States in 2017
- Rates of the 10 leading causes of death in the United States in 2017 (per 100,000 population)*
- Percentage changes in selected causes of death in the U.S. between 2000 and 2017, by disease
- Number of cancer deaths worldwide in 2016, by major type of cancer
- Deaths by cancer in the U.S. from 1950 to 2016 (per 100,000 population)*
- Number of U.S. Americans with a history of cancer living between 2004 and 2016 (in millions)
- Availability of new cancer drugs launched in 2012-2016 in selected countries as of 2017
- Deaths from ischemic heart disease in OECD countries in 2015 (per 100,000 population)
- Heart disease risk in the U.S. between 2000 and 2016, by age*
- Deaths by heart diseases in the U.S. from 1950 to 2016 (per 100,000 population)
- Estimated number of diabetics worldwide in 2017 and 2045 (in millions)
- Number of U.S. Americans with diagnosed diabetes from 1980 to 2015 (in millions)*
- Deaths by diabetes mellitus in the U.S. from 1950 to 2016 (per 100,000 population)
- Leading U.S. states based on percentage of adults who ever had diabetes as of 2017*
- Cost of dementia healthcare pathways in select countries for 2015 (in million U.S. dollars)
- Projected numbers of older people with Alzheimer’s in the U.S. from 2010 to 2050 (in millions)*
- Projected number of people aged 65 and over with Alzheimer's disease in the U.S. in 2019 and 2025, by state (in thousands)
- Distribution of Alzheimer's disease patients in the United States as of 2019, by age group
- Number of new cases of hepatitis A and B in the U.S. from 1970 to 2016
- Number of new cases of Lyme disease in the U.S. from 1991 to 2016*
- Number of new cases of meningococcal disease in the U.S. from 1970 to 2016
- Number of new cases of measles (rubeola) in the U.S. from 1950 to 2019
- Number of new cases of syphilis in the U.S. from 1950 to 2016*
- Number of new cases of tuberculosis in the U.S. from 1960 to 2016*
- Number of malaria cases in the U.S. from 2001 to 2015
- Donated funds for research and development by disease in 2017 (in million U.S. dollars)*
- Distribution of total global funding on research and development for selected diseases from 2013 to 2017
- Top countries in public funding for research and development on neglected diseases in 2017 (in million U.S. dollars)
- Percentage of top countries in public funding for research and development on neglected diseases in 2017*
- Top philanthropic funders for research and development on neglected diseases worldwide in 2017 (in million U.S. dollars)
- Percentage of top philanthropic funders for research and development on neglected diseases worldwide in 2017
- Focus of U.S. governmental focus support for late-stage neglected disease pipeline candidates in 2015
- Percentage of the population worldwide at risk of malaria who were protected by indoor residual spraying (IRS) as of 2017, by region
- Percentage of children in Canada who had received select vaccinations at 24 months in 2013 and 2015, by antigen
- Share of total disease investment in the U.S. between 2008 and 2017, by disease
- Share of licensing and acquisition deals of therapeutic companies worldwide between 2008 and 2017, by disease
- Venture funding of U.S. therapeutic companies in 2017, by disease type (in million U.S. dollars)
- Percentage of donations by charity foundations in research and development for diseases in 2007 (in percent)
- To what extent should patients be responsible for the treatment of chronic diseases?
- Distribution of total disease investment in the U.S. between 2008 and 2017, by disease and investment type
- Sport Ireland high performance sport investments in Canoeing Ireland from 2013 to 2019 (in 1,000 euros)
- Number of confirmed deaths due to botulism in Europe in 2017, by country
- Number of people registered with diabetes in England and Wales in 2013, by smoking status
- Sport Ireland high performance sport investments in the Irish Sailing Association from 2013 to 2018 (in 1,000 euros)
- Distribution of funding to performing arts in Italy in 2018, by sector
- Sport Ireland Funding of Local Sports Partnerships (LSP) in Ireland from 2014 to 2019 (in 1,000 euros)
- Distribution of financial contributions made by Chile to multilateral organizations between 2014 and 2016, by recipient organization
- Sport Ireland Funding of Dormant Account projects in Ireland in 2018 (in 1,000 euros)
- Distribution of financial contributions made by Uruguay to multilateral organizations between 2014 and 2016, by recipient organization
- Average annual amount of direct financial contributions made by Chile to multilateral organizations between 2014 and 2016, by type of recipient organization (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.